Other

Operating And Finance Lease, Right-Of-Use Asset

Moderna Operating And Finance Lease, Right-Of-Use Asset decreased by 2.5% to $742.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.5%, from $811.00M to $742.00M. Over 5 years (FY 2020 to FY 2025), Operating And Finance Lease, Right-Of-Use Asset shows an upward trend with a 39.3% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Metric ID: other_operating_and_finance_lease_right_of_use_asset_592aca

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$579.00M$531.00M$807.00M$825.00M$741.00M$1.32B$1.27B$1.15B$1.21B$1.37B$1.15B$1.13B$1.21B$1.28B$824.00M$811.00M$803.00M$785.00M$761.00M$742.00M
QoQ Change-8.3%+52.0%+2.2%-10.2%+78.4%-3.9%-9.5%+4.9%+13.3%-15.9%-1.7%+6.6%+6.4%-35.7%-1.6%-1.0%-2.2%-3.1%-2.5%
YoY Change+28.0%+149.0%+57.5%+39.4%+62.8%+3.3%-9.6%-1.7%-0.1%-6.1%-28.3%-28.2%-33.4%-38.8%-7.6%-8.5%
Range$531.00M$1.37B
CAGR+5.4%
Avg YoY Growth+11.1%
Median YoY Growth-3.9%
Current Streak6 quarters decline

Frequently Asked Questions

What is Moderna's operating and finance lease, right-of-use asset?
Moderna (MRNA) reported operating and finance lease, right-of-use asset of $742.00M in Q1 2026.
How has Moderna's operating and finance lease, right-of-use asset changed year-over-year?
Moderna's operating and finance lease, right-of-use asset decreased by 8.5% year-over-year, from $811.00M to $742.00M.
What is the long-term trend for Moderna's operating and finance lease, right-of-use asset?
Over 5 years (2020 to 2025), Moderna's operating and finance lease, right-of-use asset has grown at a 39.3% compound annual growth rate (CAGR), from $145.00M to $761.00M.